Patent · US Active

Heavy chain antibodies binding to CD22

US11873336B2 · kind B2 · utility

0Cited by

8References

14Claims

0Family size

Assignee

TeneoBio, Inc. · US

Inventors

Shelley Force Aldred · Newark, US
Wim van Schooten · Sunnyvale, US
Heather Anne N. Ogana · Thousand Oaks, US
Laura Marie Davison · Thousand Oaks, US
Katherine Harris · Newark, US
Udaya Rangaswamy · Newark, US
Nathan Trinklein · Redwood City, US

Key dates

Filing date	Dec 21, 2018
Grant date	Jan 16, 2024
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-CD22 heavy chain antibodies (e.g., UniAbs™) are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B cell disorders that are characterized by the expression of CD22.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.